Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
Clinical trial NCT05208307 · RECRUITING
Trial details
- NCT number
- NCT05208307
- Sponsor
- Emory University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2026-10-21
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.